fda drug shortage list semaglutide UPDATED: lists all doses of Novo's Wegovy as available, signaling potential end to supply rout in US GLP-1 Drugs: FDA Removes Semaglutide

More ways to help your patients with T2D Check your patients' coverage and view savings offer Ozempic is available in 3 doses for more A1C control is available in 3 doses for more A1C control ACE=angiotensin-converting enzyme

Table of Contents: What is BPC 157, and how does it work in the body

Do you serve patients outside Arizona

Dec 29, 2025 CagriSema represents the next evolution in medical weight loss - Novo Nordisk's branded combination of semaglutide 2.4mg and cagrilintide 2.4mg that produced 15-25% body weight loss in Phase 3 trials

Some individuals have naturally higher GLP-1 receptor sensitivity, meaning they experience strong appetite suppression even at lower doses, while others need more time or higher doses to reach the same effect

For GLP-1 users already dealing with nausea, bloating, or changing taste preferences, an electrolyte product without added sweeteners or strong flavors, like this one, may feel more approachable